Skip to main content
Clinical Trials/ISRCTN04707454
ISRCTN04707454
Completed
未知

Evaluation of the of the sensitivity, specificity and diagnostic accuracy of the [-2]proPSA biomarker and its derivatives for the detection of prostate cancer and determination of the relationship with prostate cancer characteristics at biopsy

Beckman Coulter Eurocenter (Switzerland)0 sites1,250 target enrollmentDecember 19, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Beckman Coulter Eurocenter (Switzerland)
Enrollment
1250
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 19, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Beckman Coulter Eurocenter (Switzerland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Male patients older than 45 years old
  • 2\. Negative/positive digital rectal examination
  • 3\. Patients subjected to previous prostate biopsy will be included and analyzed in a nested case control study
  • 4\. Patients treated with drugs that may alter serum PSA levels (Finasteride and Dutasteride) will be included and analysed later in a nested case control study

Exclusion Criteria

  • 1\. Patients with bacterial acute prostatitis and with a positive sperm culture in the last three months prior to biopsy
  • 2\. Patients subjected to previous endoscopic surgery of the prostate (TransUrethral Resection of the Prostate \[TURP] or Holmium\-laser Enucleomorcellation of the Prostate \[HoLEP]

Outcomes

Primary Outcomes

Not specified

Similar Trials